Systemic Lupus Erythematosus (SLE) is characterized by B cells lacking IgD and CD27 (double
negative; DN). We show that DN cell expansions reflected a subset of CXCR5 - CD11c + …

Systemic lupus erythematosus (SLE) is an autoimmune disease with marked gender and
ethnic disparities. We report a large transancestral association study of SLE using Immunochip …

Background Given the phenotypic similarities between rheumatoid arthritis (RA)–associated
interstitial lung disease (ILD) (hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …

Systemic lupus erythematosus (SLE, MIM152700) is an autoimmune disease characterized
by self-reactive antibodies resulting in systemic inflammation and organ failure. TNFAIP3, …

… erythematosus patients - Niewold - 2008 - Arthritis & Rheumatism - Wiley Online Library …
Niewold had full access to all of the data in the study and takes responsibility for the integrity …

Objectives Vitamin D deficiency is widespread and has been associated with many chronic
diseases, including autoimmune disorders. A study was undertaken to explore the impact of …

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disorder with a complex
pathogenesis in which genetic, hormonal and environmental factors have a role. Rare …

Objective Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE)
that exhibits familial aggregation and may progress to end‐stage renal disease (ESRD). …

Increased IFN-α signaling is a primary pathogenic factor in systemic lupus erythematosus (SLE).
STAT4 is a transcription factor that is activated by IFN-α signaling, and genetic variation …

Objective Interferon‐α (IFNα) is a primary pathogenic factor in systemic lupus erythematosus
(SLE), and high IFNα levels may be associated with particular clinical manifestations. The …